TFF3 in renal pathobiology: a novel lipotoxicity regulator in male mice with diabetic kidney disease
Journal of Endocrinology · 01.04.2026 · 269 (1)
DOI: 10.1530/joe-25-0303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinology, erschienen am 01.04.2026. Verfasst von Jinyuan Zhang und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Trefoil Factor-3, Diabetic Nephropathies, Kidney, Diabetes Mellitus, Experimental. Die Arbeit nennt 78 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Trefoil factor 3 (TFF3) is a small peptide with complex activities in different diseases. Our previous studies have indicated that TFF3 can mediate gut–kidney crosstalk in diabetic kidney disease (DKD), but the underlying mechanism remains unclear. To investigate the role of TFF3 in regulating lipotoxicity in DKD, male Tff3 −/− C57BL/6J mice were used in our study. The mice were divided into four groups: WT (wild type), WT- Tff3 −/− , Mod-WT (DKD model), and Mod- Tff3 −/− . The DKD model was established using a combination of high-fat diet and streptozotocin (STZ). Basic physiological parameters, including body weight and fasting blood glucose (FBG), were monitored biweekly. Glucolipid metabolism and renal functional parameters, including TC, TG, LDL-c, HDL-c, OGTT, ITT, UACR, and BUN, were detected by biochemical detection kits. Renal pathological examination methods including H&E and Oil Red O staining were used. Western blot analysis was performed to quantify the protein levels of SCAP, SREBP, AMPK, p-AMPK, ACC, and p-ACC in renal tissues. Our findings indicate that Tff3 deficiency in the kidney significantly alters renal lipid metabolism but not glucose metabolism. Tff3 −/− mice exhibited elevated levels of TC, TG, and LDL-c, but with no significant changes in HDL or the AUC of OGTT and ITT; additionally, Tff3 deficiency accelerates renal pathological changes, including lipid accumulation. Furthermore, Tff3 −/− mice showed up-regulation of SCAP and SREBP expression and down-regulation of p-AMPK and p-ACC in the context of DKD. In conclusion, Tff3 knockout could accelerate renal lipotoxicity by the AMPK/ACC and SCAP/SREBP signaling pathways in DKD progression, which provides a new perspective of DKD investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
ORCID-Profile: Yi-Qi Yang
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Zhang, J., Lai, L., Huang, M. L., Mei, Y., Wan, X. F., & Yang, Y. Q. (2026). TFF3 in renal pathobiology: a novel lipotoxicity regulator in male mice with diabetic kidney disease. Journal of Endocrinology, 269(1). https://doi.org/10.1530/joe-25-0303
Vancouver
Zhang J, Lai L, Huang ML, Mei Y, Wan XF, Yang YQ. TFF3 in renal pathobiology: a novel lipotoxicity regulator in male mice with diabetic kidney disease. Journal of Endocrinology. 2026;269(1). doi:10.1530/joe-25-0303
BibTeX
@article{Zhang2026,
author = {Zhang, Jinyuan and Lai, Li and Huang, Mei-Lan and Mei, Yang and Wan, Xiao-Fen and Yang, Yi-Qi},
title = {TFF3 in renal pathobiology: a novel lipotoxicity regulator in male mice with diabetic kidney disease},
journal = {Journal of Endocrinology},
year = {2026},
volume = {269},
number = {1},
doi = {10.1530/joe-25-0303}
}
EUVIMED